Cargando…
Cimetidine modulates the antigen presenting capacity of dendritic cells from colorectal cancer patients
Cimetidine, a H(2) receptor antagonist, has been reported to improve survival in gastrointestinal cancer patients. These effects have largely been attributed to the enhancing effects of cimetidine on the host's antitumour cell-mediated immune response, such as inhibition of suppressor T lymphoc...
Autores principales: | Kubota, T, Fujiwara, H, Ueda, Y, Itoh, T, Yamashita, T, Yoshimura, T, Okugawa, K, Yamamoto, Y, Yano, Y, Yamagishi, H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375332/ https://www.ncbi.nlm.nih.gov/pubmed/11953882 http://dx.doi.org/10.1038/sj.bjc.6600233 |
Ejemplares similares
-
Identification of two novel CT antigens and their capacity to elicit antibody response in hepatocellular carcinoma patients
por: Dong, X-Y, et al.
Publicado: (2003) -
Identification of parathyroid hormone-related protein-derived peptides immunogenic in human histocompatibility leukocyte antigen-A24(+) prostate cancer patients
por: Yao, A, et al.
Publicado: (2004) -
Overexpression of leucocyte common antigen (LAR) P-subunit in thyroid carcinomas
por: Konishi, N, et al.
Publicado: (2003) -
UDP-Gal: βGlcNAc β1, 3-galactosyltransferase, polypeptide 3 (GALT3) is a tumour antigen recognised by HLA-A2-restricted cytotoxic T lymphocytes from patients with brain tumour
por: Tsuda, N, et al.
Publicado: (2002) -
Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation
por: Fukuda, K, et al.
Publicado: (2004)